One theory is that there may be an NLRP1 negative regulatory factor that is downregulated in RA inflammatory responses and that inhibits NLRP1 assembly and caspase-1 activation through the NLRP1-signaling pathway [19]. The gene discussed is CASP1; the disease is rheumatoid arthritis.